Agalsidase beta (Fabrazyme) for Fabry disease.
D023341:Chills / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D000795:Fabry Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D016032:Randomized Controlled Trials as Topic; D000519:alpha-Galactosidase / Q000009:adverse effects / Q000627:therapeutic use*
D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta